Literature DB >> 12224130

Establishment and characterization of a new osteogenic cell line (MOS-J) from a spontaneous C57BL/6J mouse osteosarcoma.

Melissa J Joliat1, Syuji Umeda, Bonnie L Lyons, Michael A Lynes, Leonard D Shultz.   

Abstract

In this paper we describe the establishment and characterization of a transplantable cell line derived from a spontaneously occurring chondroblastic osteosarcoma in a C57BL/6J mouse. The tumor line, MOS-J, forms solid tumors when injected intramuscularly into immunocompetent syngeneic hosts, mimicking endochondral bone development. These transplantable tumors have the capacity to destroy and invade existing bone and invade vessels in close proximity to the tumor. In culture, MOS-J cells form layers of pleomorphic cells with high mitotic activity. These cells have marked alkaline phosphatase activity and form calcified foci in vitro that stain with alizarin red. MOS-J cells also promote osteoclast development in vitro from normal bone marrow cells. These characteristics indicate the potential utility of the MOS-J osteosarcoma cell line as a model for studies of human osteosarcoma and bone biology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12224130

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  14 in total

1.  Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process.

Authors:  Gatien Moriceau; Benjamin Ory; Laura Mitrofan; Chiara Riganti; Frédéric Blanchard; Régis Brion; Céline Charrier; Séverine Battaglia; Paul Pilet; Marc G Denis; Leonard D Shultz; Jukka Mönkkönen; Françoise Rédini; Dominique Heymann
Journal:  Cancer Res       Date:  2010-10-22       Impact factor: 12.701

2.  Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury.

Authors:  Anne-Laure Leblond; Patrice Naud; Virginie Forest; Clothilde Gourden; Christine Sagan; Bénédicte Romefort; Eva Mathieu; Bruno Delorme; Christine Collin; Jean-Christophe Pagès; Luc Sensebé; Bruno Pitard; Patricia Lemarchand
Journal:  Hum Gene Ther       Date:  2009-11       Impact factor: 5.695

Review 3.  Primary neoplasms of bones in mice: retrospective study and review of literature.

Authors:  A M Kavirayani; J P Sundberg; O Foreman
Journal:  Vet Pathol       Date:  2011-02-22       Impact factor: 2.221

4.  Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory.

Authors:  Naiara Martinez-Velez; Virginia Laspidea; Marta Zalacain; Ana Patiño-García; Marta M Alonso; Sara Labiano; Marc García-Moure; Montse Puigdelloses; Lucía Marrodan; Marisol Gonzalez-Huarriz; Guillermo Herrador; Daniel de la Nava; Iker Ausejo-Mauleon; Juan Fueyo; Candelaria Gomez-Manzano
Journal:  Mol Cancer Ther       Date:  2022-03-01       Impact factor: 6.261

5.  Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling.

Authors:  Vincent Crenn; Kevin Biteau; Jérôme Amiaud; Clotilde Dumars; Romain Guiho; Luciano Vidal; Louis-Romée Le Nail; Dominique Heymann; Anne Moreau; François Gouin; Françoise Redini
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

6.  Conditioned media from mouse osteosarcoma cells promote MC3T3-E1 cell proliferation using JAKs and PI3-K/Akt signal crosstalk.

Authors:  Kanji Mori; Frederic Blanchard; Celine Charrier; Severine Battaglia; Kosei Ando; Laurence Duplomb; Leonard D Shultz; Francoise Redini; Dominique Heymann
Journal:  Cancer Sci       Date:  2008-10-18       Impact factor: 6.716

7.  Established gastric cancer cell lines transplantable into C57BL/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth.

Authors:  Masami Yamamoto; Sachiyo Nomura; Akihiro Hosoi; Koji Nagaoka; Tamaki Iino; Tomohiko Yasuda; Tomoko Saito; Hirokazu Matsushita; Eiji Uchida; Yasuyuki Seto; James R Goldenring; Kazuhiko Kakimi; Masae Tatematsu; Tetsuya Tsukamoto
Journal:  Cancer Sci       Date:  2018-04-15       Impact factor: 6.716

8.  An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity.

Authors:  U Krause; D M Ryan; B H Clough; C A Gregory
Journal:  Cell Death Dis       Date:  2014-02-27       Impact factor: 8.469

9.  Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine models.

Authors:  Bérengère Gobin; Gatien Moriceau; Benjamin Ory; Céline Charrier; Régis Brion; Frederic Blanchard; Françoise Redini; Dominique Heymann
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases.

Authors:  Benjamin Navet; Kosei Ando; Jorge William Vargas-Franco; Régis Brion; Jérome Amiaud; Kanji Mori; Hideo Yagita; Christopher G Mueller; Franck Verrecchia; Clotilde Dumars; Marie-Françoise Heymann; Dominique Heymann; Frédéric Lézot
Journal:  Cancers (Basel)       Date:  2018-10-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.